Accendra Health (ACH) earnings

ACCENDRA HEALTH INC/VA/· Health Care

Results to: Jun 2026
Latest analysed call: Jun 2026 (Q2 FY26)
Balance sheet to: Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

Accendra Health earnings: last reported Mon, 10 Aug 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

Metric	Value	Change	Basis	Period	Note
Revenue	613 $ million	−10.1% YoY	Quarterly, as filed	Quarter to Jun 2026	Revenue from operations as filed.
Operating margin	-5.7 %	+0.1 pts YoY	Operating profit / revenue	Quarter to Jun 2026	For the quarter; a change is in percentage points.
Net profit	-89.1 $ million	—	Quarterly, as filed	Quarter to Jun 2026	Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.

Source: Inve data from filed results (SEC filings) · to Jun 2026

Price

$0.22 −8.33% · −$0.02

Last close Oct 19, 2026 · US · USD

Performance −95.4% 1Y

1Y: $4.8 on 17 Oct 2025 → $0.22. High $5.51 (24 Oct 2025), low $0.22 (19 Oct 2026).

Previous close: $0.24
52-week range: $0.22 – $5.51
One year: −95.55%

Overview

Symbol: ACH
Sector: Health Care
Exchange: US
Currency: USD

Financials

What the filings say

Net profit, year on year: +90% (quarter to jun 2026 against jun 2025).

In $ million. Oldest period first.

Line item	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	687	2,696	674	682	697	709	628	613
Operating profit	31	-262	20	-40	26	21	17	-35
Operating margin	4.5%	−9.7%	2.9%	−5.8%	3.8%	3.0%	2.7%	−5.7%
Other income	-1	-1	-1	-1	-1	-1	-1	-1
Interest	29	—	24	26	29	28	32	35
Profit before tax	1	-300	-5	-85	-4	-8	-16	-88
Tax rate	−31.6%	1.2%	29.4%	1.3%	−54.3%	−18.5%	60.2%	−1.6%
Net profit	-13	-296	-25	-869	-150	-56	-6	-89
EPS ($ per share)	-0.17	—	-0.32	-11.30	-1.94	—	-0.08	-1.16

Source: Inve data · income statement, quarterly · to Jun 2026

In $ million. Oldest period first.

Line item	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Equity capital	125	126	147	151	153	153	154	153
Reserves	201	138	167	388	410	369	27	-1,080
Total liabilities	3,255	3,181	2,624	2,598	4,441	4,169	4,070	2,913
Fixed assets	324	315	316	317	578	544	249	256
Total assets	3,774	3,643	3,336	3,537	5,386	5,093	4,656	2,452

Source: Inve data · balance sheet · to Dec 2025

In $ million. Oldest period first.

Line item	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from operations	116	166	339	124	325	741	161	-102
Cash from investing	-816	-52	80	-54	-1,804	-137	-117	144
Cash from financing	701	-130	-379	-129	1,497	-417	-268	188
Net cash flow	-1	-19	50	-62	14	187	-224	233
Capital expenditure	-45	-42	-50	-41	-158	-172	-170	-191
Free cash flow	71	124	289	83	167	568	-9	-293

Source: Inve data · cash flow · to Dec 2025

Insider filings

19 filings between Nov 19, 2025 and Oct 5, 2026.

Open market

decisions to buy or sell

Nobody bought or sold ACH on the open market in this window. The filings below are 8 awards, 10 tax withholdings and 1 gift.

Compensation

not trading decisions

8: Award — granted as compensation
10: Tax withheld — shares kept back by the company to cover tax

Latest filings (50)

Date	Insider	What	Shares	Value
Oct 5, 2026	Gardner-Smith Kenneth President & CEO	Award	283,554	$0
Sep 23, 2026	Leon Jonathan A EVP & CFO	Tax withheld	4,265	$3.6K
May 18, 2026	Galloway Heath H EVP,General Counsel & CorpSecy	Tax withheld	1,822	$5.3K
May 15, 2026	Pesicka Edward A President & CEO	Tax withheld	17,692	$53.8K
May 15, 2026	Leon Jonathan A EVP & CFO	Tax withheld	1,770	$5.4K
May 15, 2026	Galloway Heath H EVP,General Counsel & CorpSecy	Tax withheld	966	$2.9K
May 15, 2026	Bernocchi Perry A EVP, Chief Operating Officer	Tax withheld	7,908	$24.0K
May 14, 2026	Klemash Stephen W Director	Award	31,191	$0
May 14, 2026	Kline Teresa L. Director	Award	31,191	$0
May 14, 2026	Beck Mark A Director	Award	31,191	$0
May 14, 2026	Gardner-Smith Kenneth Director	Award	31,191	$0
Mar 20, 2026	Leon Jonathan A EVP & CFO	Tax withheld	11,286	$22.9K
Mar 20, 2026	Pesicka Edward A President & CEO	Tax withheld	58,945	$119.7K
Mar 20, 2026	Galloway Heath H EVP,General Counsel & CorpSecy	Tax withheld	9,347	$19.0K
Mar 20, 2026	Bernocchi Perry A EVP, Chief Operating Officer	Tax withheld	20,841	$42.3K
Mar 9, 2026	Bernocchi Perry A EVP, Chief Operating Officer	Award	108,696	$0
Mar 9, 2026	Galloway Heath H EVP,General Counsel & CorpSecy	Award	61,437	$0
Mar 9, 2026	Leon Jonathan A EVP & CFO	Award	85,067	$0
Nov 19, 2025	Long Andrew G EVP, CEO P&HS	Gift	47,908	$0
Sep 23, 2025	Leon Jonathan A EVP & CFO	Tax withheld	4,265	$23.0K
Aug 14, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	492,852	$2.62M
Aug 13, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	325,000	$1.77M
Aug 12, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	720,000	$3.71M
Jun 3, 2025	Stone Jennifer A EVP, CHRO	Tax withheld	5,764	$36.6K
May 19, 2025	Galloway Heath H EVP,General Counsel & CorpSecy	Tax withheld	1,768	$13.0K
Apr 10, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	80,000	$575.2K
Apr 9, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	225,000	$1.66M
Apr 8, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	105,000	$835.8K
Apr 7, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	240,000	$1.88M
Apr 4, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	128,356	$1.04M
Apr 3, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	160,000	$1.36M
Mar 20, 2025	Lowry Michael Wayne SVP, Corporate Controller	Tax withheld	1,059	$10.7K
Mar 20, 2025	Long Andrew G EVP, CEO P&HS	Tax withheld	4,578	$46.2K
Mar 20, 2025	Leon Jonathan A EVP & CFO	Tax withheld	1,961	$19.8K
Mar 20, 2025	Bernocchi Perry A EVP, CEO,. Patient Direct	Tax withheld	5,551	$56.0K
Mar 20, 2025	Galloway Heath H EVP,General Counsel & CorpSecy	Tax withheld 10b5-1 plan	2,734	$27.6K
Mar 20, 2025	Pesicka Edward A President & CEO	Tax withheld	14,715	$148.5K
Mar 20, 2025	Sarkar Snehashish Insider	Tax withheld	1,977	$19.9K
Mar 4, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	800,000	$7.80M
Mar 3, 2025	Long Andrew G EVP, CEO P&HS	Award	134,121	$0
Mar 3, 2025	Leon Jonathan A EVP, Chief Financial Officer	Award	134,121	$0
Mar 3, 2025	Bernocchi Perry A EVP, CEO,. Patient Direct	Award	123,391	$0
Mar 3, 2025	Lowry Michael Wayne SVP, Corporate Controller	Award	28,166	$0
Mar 3, 2025	Galloway Heath H EVP,General Counsel & CorpSecy	Award	69,743	$0
Mar 3, 2025	Pesicka Edward A President & CEO	Award	445,279	$0
Mar 3, 2025	Stone Jennifer A EVP, CHRO	Award	59,013	$0
Mar 3, 2025	Sarkar Snehashish Insider	Award	59,013	$0
Mar 3, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	354,901	$3.26M
Feb 28, 2025	Coliseum Capital Management, LLC 10% owner	Purchase	1,738,511	$16.32M
Nov 21, 2024	Leon Jonathan A EVP, Chief Financial Officer	Sale 10b5-1 plan	5,282	$62.4K

Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.

Your own record

Start an Inve Case for ACCENDRA HEALTH INC/VA/

Free account. Everything above stays public.

Write why you follow ACCENDRA HEALTH INC/VA/ and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds

Keep reading